Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens
疫苗型免疫疗法(VBIR)的临床前开发,该疗法可诱导针对肿瘤相关自身抗原的强效且持久的T细胞反应
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-022-03245-x
Cho, Helen; Binder, Joe; Weeratna, Risini; Dermyer, Michael; Dai, Stanley; Boccia, Antionio; Li, Wei; Li, Shangjin; Jooss, Karin; Merson, James; Hollingsworth, Robert E